Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: fyi...the initial rejection of the 148 has been reversed..buying time IMO

I beleive my questions are answered by Milesones post number 873688 on the OT forum. I like this part of it. "In some cases, however, second, third or fourth non final office actions are arguably the result of poor office action quality rather than the quality of the patentability arguments."

All the best,

Steve

Share
New Message
Please login to post a reply